Retinoblastoma

Kamihara J, Bourdeaut F, Foulkes WD, et al. Retinoblastoma and neuroblastoma predisposition and surveillance. Clin Cancer Res. 2017 Jul 1;23(13):e98-106.Texto completo  Resumo

Global Retinoblastoma Study Group. The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries. Lancet Glob Health. 2022 Aug;10(8):e1128-40.Texto completo  Resumo

Skalet AH, Gombos DS, Gallie BL, et al. Screening children at risk for retinoblastoma: consensus report from the American Association of Ophthalmic Oncologists and Pathologists. Ophthalmology. 2018 Mar;125(3):453-8.Texto completo  Resumo

de Graaf P, Göricke S, Rodjan F, et al. Guidelines for imaging retinoblastoma: imaging principles and MRI standardization. Pediatr Radiol. 2012 Jan;42(1):2-14.Texto completo  Resumo

American College of Radiology. ACR appropriateness criteria: orbits, vision and visual loss. 2017 [internet publication].Texto completo

Hutchinson AK, Morse CL, Hercinovic A, et al. Pediatric eye evaluations preferred practice pattern. Ophthalmology. 2023 Mar;130(3):P222-70.Texto completo  Resumo

1. Villegas VM, Hess DJ, Wildner A, et al. Retinoblastoma. Curr Opin Ophthalmol. 2013 Nov;24(6):581-8 Resumo

2. National Organization for Rare Disorders. Rare diseases database. Retinoblastoma. 2017 [internet publication].Texto completo

3. Schefler AC, Abramson DH. Retinoblastoma: what is new in 2007-2008. Curr Opin Ophthalmol. 2008 Nov;19(6):526-34. Resumo

4. Akdeniz Odemis D, Kebudi R, Bayramova J, et al. RB1 gene mutations and genetic spectrum in retinoblastoma cases. Medicine (Baltimore). 2023 Sep 8;102(36):e35068.Texto completo  Resumo

5. Chai P, Luo Y, Yu J, et al. Clinical characteristics and germline mutation spectrum of RB1 in Chinese patients with retinoblastoma: a dual-center study of 145 patients. Exp Eye Res. 2021 Apr;205:108456. Resumo

6. Linn Murphree A. Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin N Am. 2005 Mar;18(1):41-53, Resumo

7. Abramson DH, Schefler AC. Update on retinoblastoma. Retina. 2004 Dec;24(6):828-48. Resumo

8. Cassoux N, Lumbroso L, Levy-Gabriel C, et al. Retinoblastoma: update on current management. Asia Pac J Ophthalmol (Phila). 2017 May-Jun;6(3):290-5. Resumo

9. Global Retinoblastoma Study Group, Fabian ID, Abdallah E, et al. Global retinoblastoma presentation and analysis by national income level. JAMA Oncol. 2020 May 1;6(5):685-95.Texto completo  Resumo

10. Ghose N, Agarwal P, Palkonda VAR, et al. Retinoblastoma associated with total exudative retinal detachment: treatment and outcomes. Retina. 2023 May 1;43(5):808-14. Resumo

11. Ortiz MV, Dunkel IJ. Retinoblastoma. J Child Neurol. 2016 Feb;31(2):227-36. Resumo

12. Walinjkar J, Krishnakumar S, Gopal L, et al. Retinoblastoma presenting with orbital cellulitis. J AAPOS. 2013 Jun;17(3):282-6. Resumo

13. O'Brien JM. Retinoblastoma: clinical presentation and the role of neuroimaging. AJNR Am J Neuroradiol. 2001 Mar;22(3):426-8.Texto completo  Resumo

14. Kamihara J, Bourdeaut F, Foulkes WD, et al. Retinoblastoma and neuroblastoma predisposition and surveillance. Clin Cancer Res. 2017 Jul 1;23(13):e98-106.Texto completo  Resumo

15. Ballarati L, Elena Rossi E, Bonati MT, et al. 13q deletion and central nervous system anomalies: further insights from karyotype - phenotype analyses of 14 patients. J Med Genet. 2007;44:e60. Resumo

16. Tamboli A, Podgor MJ, Horm JW. The incidence of retinoblastoma in the United States: 1974 through 1985. Arch Ophthalmol. 1990 Jan;108(1):128-32. Resumo

17. Aerts I, Lumbroso-Le Rouic L, Gauthier-Villars M, et al. Retinoblastoma. Orphanet J Rare Dis. 2006 Aug 25;1:31.Texto completo  Resumo

18. Fernandes AG, Pollock BD, Rabito FA. Retinoblastoma in the United States: a 40-year incidence and survival analysis. J Pediatr Ophthalmol Strabismus. 2018 May 1;55(3):182-8. Resumo

19. Wong JR, Tucker MA, Kleinerman RA, et al. Retinoblastoma incidence patterns in the US Surveillance, Epidemiology, and End Results program. JAMA Ophthalmol. 2014 Apr 1;132(4):478-83. Resumo

20. Childhood Eye Cancer Trust. Information about retinoblastoma for health professionals. [internet publication].Texto completo

21. Global Retinoblastoma Study Group. The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries. Lancet Glob Health. 2022 Aug;10(8):e1128-40.Texto completo  Resumo

22. Dimaras H, Kimani K, Dimba EA, et al. Retinoblastoma. Lancet. 2012 Apr 14;379(9824):1436-46.Texto completo  Resumo

23. Mohammad M, Mehyar M, Halalsheh H, et al. The impact of tumor laterality (unilateral vs. bilateral) on presentation and management outcome in patients with retinoblastoma. J Clin Med. 2024 Apr 8;13(7):2146.Texto completo  Resumo

24. Dimaras H, Khetan V, Halliday W, et al. Loss of RB1 induces non-proliferative retinoma; increasing genomic instability correlates with progression to retinoblastoma. Hum Mol Genet. 2008 May 15;17(10):1363-72. Resumo

25. Houston SK, Pina Y, Clarke J, et al. Regional and temporal differences in gene expression of LH(BETA)T(AG) retinoblastoma tumors. Invest Ophthalmol Vis Sci. 2011 Jul 23;52(8):5359-68.Texto completo  Resumo

26. Leiderman YI, Kiss S, Mukai S. Molecular genetics of RB1 - the retinoblastoma gene. Semin Ophthalmol. 2007 Oct-Dec;22(4):247-54. Resumo

27. Orjuela M, Castaneda VP, Ridaura C, et al. Presence of human papilloma virus in tumor tissue from children with retinoblastoma: an alternative mechanism for tumor development. Clin Cancer Res. 2000 Oct;6(10):4010-6.Texto completo  Resumo

28. Mohan A, Venkatesan N, Kandalam M, et al. Detection of human papillomavirus DNA in retinoblastoma samples: a preliminary study. J Pediatr Hematol Oncol. 2009 Jan;31(1):8-13. Resumo

29. Feng H, Deng Y. Human papillomavirus and retinoblastoma: evidence from a systematic review and meta-analysis of cross-sectional studies. Int J Public Health. 2023 Jul 11:68:1605284.Texto completo  Resumo

30. Soltani S, Tabibzadeh A, Yousefi P, et al. HPV infections in retinoblastoma: a systematic review. J Clin Lab Anal. 2021 Oct;35(10):e23981.Texto completo  Resumo

31. Dryja TP, Mukai S, Petersen R, et al. Parental origin of mutations of the retinoblastoma gene. Nature. 1989 Jun 15;339(6225):556-8. Resumo

32. DerKinderen DJ, Koten JW, Tan KE, et al. Parental age in sporadic hereditary retinoblastoma. Am J Ophthalmol. 1990 Dec 15;110(6):605-9. Resumo

33. Matsunaga E, Minoda K, Sasaki MS. Parental age and seasonal variation in the births of children with sporadic retinoblastoma: a mutation-epidemiologic study. Hum Genet. 1990 Jan;84(2):155-8. Resumo

34. Tanwar M, Balaji S, Vanniarajan A, et al. Parental age and retinoblastoma-a retrospective study of demographic data and genetic analysis. Eye (Lond). 2022 Jan;36(1):57-63.Texto completo  Resumo

35. Saremi L, Imani S, Rostaminia M, et al. Parental age-related risk of retinoblastoma in Iranian children. Asian Pac J Cancer Prev. 2014;15(6):2847-50.Texto completo  Resumo

36. Ajioka I, Dyer MA. A new model of tumor susceptibility following tumor suppressor gene activation. Cell Cycle. 2008 Mar 15;7(6):735-40. Resumo

37. Xu K, Rosenwaks Z, Beaverson K, et al. Preimplantation genetic diagnosis for retinoblastoma: the first reported liveborn. Am J Ophthalmol. 2004 Jan;137(1):18-23. Resumo

38. Skalet AH, Gombos DS, Gallie BL, et al. Screening children at risk for retinoblastoma: consensus report from the American Association of Ophthalmic Oncologists and Pathologists. Ophthalmology. 2018 Mar;125(3):453-8.Texto completo  Resumo

39. Truong B, Green AL, Friedrich P, et al. Ethnic, racial, and socioeconomic disparities in retinoblastoma. JAMA Pediatr. 2015 Dec;169(12):1096-104. Resumo

40. American Academy of Ophthalmology. Review of retinoblastoma. ​Apr 2016 [internet publication].Texto completo

41. Houston SK, Berrocal AM, Murray TG. The future of diagnostic imaging in retinoblastoma. J AAPOS. 2011 Apr;15(2):125-6. Resumo

42. de Graaf P, Göricke S, Rodjan F, et al. Guidelines for imaging retinoblastoma: imaging principles and MRI standardization. Pediatr Radiol. 2012 Jan;42(1):2-14.Texto completo  Resumo

43. American College of Radiology. ACR appropriateness criteria: orbits, vision and visual loss. 2017 [internet publication].Texto completo

44. Rauschecker AM, Patel CV, Yeom KW, et al. High-resolution MR imaging of the orbit in patients with retinoblastoma. Radiographics. 2012 Sep-Oct;32(5):1307-26.Texto completo  Resumo

45. Mohney BG, Robertson DM. Ancillary testing for metastasis in patients with newly diagnosed retinoblastoma. Am J Ophthalmol. 1994 Dec 15;118(6):707-11. Resumo

46. Stenfelt S, Blixt MKE, All-Ericsson C, et al. Heterogeneity in retinoblastoma: a tale of molecules and models. Clin Transl Med. 2017 Nov 9;6(1):42.Texto completo  Resumo

47. Rodriguez-Galindo C, Orbach DB, VanderVeen D. Retinoblastoma. Pediatr Clin North Am. 2015 Feb;62(1):201-23. Resumo

48. Berry JL, Pike S, Shah R, et al. Aqueous humor liquid biopsy as a companion diagnostic for retinoblastoma: implications for diagnosis, prognosis, and therapeutic options: five years of progress. Am J Ophthalmol. 2024 Jul;263:188-205.Texto completo  Resumo

49. Ghose N, Kaliki S. Liquid biopsy in retinoblastoma: a review. Semin Ophthalmol. 2022 Oct-Nov;37(7-8):813-9.Texto completo  Resumo

50. Silva RA, Dubovy SR, Fernandes CE, et al. Retinoblastoma with Coats' response. Ophthalmic Surg Lasers Imaging. 2011 Dec 16;42 Online:e139-43. Resumo

51. Hutchinson AK, Morse CL, Hercinovic A, et al. Pediatric eye evaluations preferred practice pattern. Ophthalmology. 2023 Mar;130(3):P222-70.Texto completo  Resumo

52. Gerrish A, Bowns B, Mashayamombe-Wolfgarten C, et al. Non-invasive prenatal diagnosis of retinoblastoma inheritance by combined targeted sequencing strategies. J Clin Med. 2020 Oct 30;9(11):3517.Texto completo  Resumo

53. American Academy of Ophthalmology. Retinoblastoma. Feb 2024 [internet publication].Texto completo

54. Meel R, Kulkarni S, Singh L, et al. Management of intraocular retinoblastoma: ICMR consensus guidelines. Indian J Pediatr. 2024 Apr 13. Resumo

55. Royal College of Pathologists. Standards and datasets for reporting cancers. Dataset for histopathological reporting of ocular retinoblastoma. January 2018 [internet publication].Texto completo

56. Chantada GL, Doz F, Orjuela M, et al. World disparities in risk definition and management of retinoblastoma: a report from the International Retinoblastoma Staging Working Group. Pediatr Blood Cancer. 2008 Mar;50(3):692-4. Resumo

57. Howarth C, Meyer D, Hustu HO, et al. Stage-related combined modality treatment of retinoblastoma. Results of a prospective study. Cancer. 1980 Mar 1;45(5):851-8. Resumo

58. Abramson DH, Ellsworth RM. The surgical management of retinoblastoma. Ophthalmic Surg. 1980 Sep;11(9):596-8. Resumo

59. Schefler AC, Cicciarelli N, Feuer W, et al. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation. Ophthalmology. 2007 Jan;114(1):162-9. Resumo

60. Gobin YP, Dunkel IJ, Marr BP, et al. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience. Arch Ophthalmol. 2011 Jun;129(6):732-7. Resumo

61. Lumbroso-Le Rouic L, Blanc R, Saint Martin C, et al. Selective ophthalmic artery chemotherapy with melphalan in the management of unilateral retinoblastoma: a prospective study. Ophthalmol Retina. 2021 Aug;5(8):e30-7. Resumo

62. Francis JH, Roosipu N, Levin AM, et al. Current treatment of bilateral retinoblastoma: the impact of intraarterial and intravitreous chemotherapy. Neoplasia. 2018 Aug;20(8):757-63.Texto completo  Resumo

63. Abramson DH, Daniels AB, Marr BP, et al. Intra-arterial chemotherapy (ophthalmic artery chemosurgery) for group D retinoblastoma. PLoS One. 2016 Jan 12;11(1):e0146582.Texto completo  Resumo

64. Chen Q, Zhang B, Dong Y, et al. Comparison between intravenous chemotherapy and intra-arterial chemotherapy for retinoblastoma: a meta-analysis. BMC Cancer. 2018 Apr 27;18(1):486.Texto completo  Resumo

65. Wen X, Fan J, Jin M, et al. Intravenous versus super-selected intra-arterial chemotherapy in children with advanced unilateral retinoblastoma: an open-label, multicentre, randomised trial. Lancet Child Adolesc Health. 2023 Sep;7(9):613-20. Resumo

66. Cao Y, Zhou M, Tian M, et al. The safety and effectiveness of melphalan-based intra-arterial chemotherapy for retinoblastoma: an updated single-arm systematic review and meta-analysis. Evid Based Complement Alternat Med. 2022 Feb 14:2022:3156503.Texto completo  Resumo

67. Ghassemi F, Shields CL. Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma. Arch Ophthalmol. 2012 Oct;130(10):1268-71.Texto completo  Resumo

68. Francis JH, Brodie SE, Marr B, et al. Efficacy and toxicity of intravitreous chemotherapy for retinoblastoma: four-year experience. Ophthalmology. 2017 Apr;124(4):488-95. Resumo

69. Francis JH, Iyer S, Gobin YP, et al. Retinoblastoma vitreous seed clouds (class 3): a comparison of treatment with ophthalmic artery chemosurgery with or without intravitreous and periocular chemotherapy. Ophthalmology. 2017 Oct;124(10):1548-55. Resumo

70. Munier FL, Gaillard MC, Balmer A, et al. Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications. Br J Ophthalmol. 2012 Aug;96(8):1078-83. Resumo

71. Smith SJ, Smith BD. Evaluating the risk of extraocular tumour spread following intravitreal injection therapy for retinoblastoma: a systematic review. Br J Ophthalmol. 2013 Oct;97(10):1231-6. Resumo

72. Shields CL, Douglass AM, Beggache M, et al. Intravitreous chemotherapy for active vitreous seeding from retinoblastoma: outcomes after 192 consecutive injections - the 2015 Howard Naquin lecture. Retina. 2016 Jun;36(6):1184-90. Resumo

73. Ministry of Health and Family Welfare India. Retinoblastoma: standard treatment guidelines. 2016 [internet publication].Texto completo

74. Houston SK, Wykoff CC, Berrocal AM, et al. Lasers for the treatment of intraocular tumors. Lasers Med Sci. 2013 May;28(3):1025-34. Resumo

75. Manjandavida FP, Honavar SG, Reddy VA, et al. Management and outcome of retinoblastoma with vitreous seeds. Ophthalmology. 2014 Feb;121(2):517-24. Resumo

76. Gündüz AK, Mirzayev I, Temel E, et al. A 20-year audit of retinoblastoma treatment outcomes. Eye (Lond). 2020 Oct;34(10):1916-24.Texto completo  Resumo

77. Tomar AS, Finger PT, Gallie B, et al. Retinoblastoma seeds: impact on American Joint Committee on Cancer clinical staging. Br J Ophthalmol. 2023 Jan;107(1):127-32.Texto completo  Resumo

78. Leng T, Cebulla CM, Schefler AC, et al. Focal periocular carboplatin chemotherapy avoids systemic chemotherapy for unilateral, progressive retinoblastoma. Retina. 2010;30(suppl 4):S66-8. Resumo

79. Mulvihill A, Budning A, Jay V, et al. Ocular motility changes after subtenon carboplatin chemotherapy for retinoblastoma. Arch Ophthalmol. 2003 Aug;121(8):1120-4. Resumo

80. Schmack I, Hubbard GB, Kang SJ, et al. Ischemic necrosis and atrophy of the optic nerve after periocular carboplatin injection for retinoblastoma. Am J Ophthalmol. 2006 Aug;142(2):310-5. Resumo

81. Uusitalo MS, Van Quill KR, Scott IU, et al. Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination. Arch Ophthalmol. 2001 Jan;119(1):41-8. Resumo

82. Chantada GL, Dunkel IJ, de Dávila MT, et al. Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy? Br J Ophthalmol. 2004 Aug;88(8):1069-73.Texto completo  Resumo

83. Zelter M, Damel A, Gonzalez G, et al. A prospective study on the treatment of retinoblastoma in 72 patients. Cancer. 1991 Oct 15;68(8):1685-90. Resumo

84. Kiratli H, Bilgiç S, Ozerdem U. Management of massive orbital involvement of intraocular retinoblastoma. Ophthalmology. 1998 Feb;105(2):322-6. Resumo

85. Goble RR, McKenzie J, Kingston JE, et al. Orbital recurrence of retinoblastoma successfully treated by combined therapy. Br J Ophthalmol. 1990 Feb;74(2):97-8.Texto completo  Resumo

86. Doz F, Khelfaoui F, Mosseri V, et al. The role of chemotherapy in orbital involvement of retinoblastoma: the experience of a single institution with 33 patients. Cancer. 1994 Jul 15;74(2):722-32. Resumo

87. Sandri A, Besenzon L, Acquaviva A, et al. "Eight drugs in one day" chemotherapy in a nonfamilial bilateral retinoblastoma with recurrent cerebrospinal fluid metastases. Pediatr Hematol Oncol. 1998 Nov-Dec;15(6):557-61. Resumo

88. Doz F, Neuenschwander S, Plantaz D, et al. Etoposide and carboplatin in extraocular retinoblastoma: a study by the Société Française d'Oncologie Pédiatrique. J Clin Oncol. 1995 Apr;13(4):902-9. Resumo

89. Namouni F, Doz F, Tanguy ML, et al. High-dose chemotherapy with carboplatin, etoposide and cyclophosphamide followed by a haematopoietic stem cell rescue in patients with high-risk retinoblastoma: a SFOP and SFGM study. Eur J Cancer. 1997 Dec;33(14):2368-75. Resumo

90. White L. Chemotherapy for retinoblastoma. Med Pediatr Oncol. 1995 May;24(5):341-2. Resumo

91. Schouten-Van Meeteren AY, Moll AC, Imhof SM, et al. Overview: chemotherapy for retinoblastoma: an expanding area of clinical research. Med Pediatr Oncol. 2002 Jun;38(6):428-38. Resumo

92. Matsubara H, Makimoto A, Higa T, et al. A multidisciplinary treatment strategy that includes high-dose chemotherapy for metastatic retinoblastoma without CNS involvement. Bone Marrow Transplant. 2005 Apr;35(8):763-6. Resumo

93. Kremens B, Wieland R, Reinhard H, et al. High-dose chemotherapy with autologous stem cell rescue in children with retinoblastoma. Bone Marrow Transplant. 2003 Feb;31(4):281-4. Resumo

94. Hertzberg H, Kremens B, Velten I, et al. Recurrent disseminated retinoblastoma in a 7-year-old girl treated successfully by high-dose chemotherapy and CD34-selected autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 2001 Mar;27(6):653-5. Resumo

95. Dunkel IJ, Aledo A, Kernan NA, et al. Successful treatment of metastatic retinoblastoma. Cancer. 2000 Nov 15;89(10):2117-21. Resumo

96. Shields CL, Shields JA, Cater J, et al. Plaque radiotherapy for retinoblastoma: long-term tumor control and treatment complications in 208 tumors. Ophthalmology. 2001 Nov;108(11):2116-21. Resumo

97. Merchant TE, Gould CJ, Wilson MW, et al. Episcleral plaque brachytherapy for retinoblastoma. Pediatr Blood Cancer. 2004 Aug;43(2):134-9. Resumo

98. Scott IU, Murray TG, Feuer WJ, et al. External beam radiotherapy in retinoblastoma: tumor control and comparison of 2 techniques. Arch Ophthalmol. 1999 Jun;117(6):766-70. Resumo

99. Abramson DH, Beaverson KL, Chang ST, et al. Outcome following initial external beam radiotherapy in patients with Reese-Ellsworth group Vb retinoblastoma. Arch Ophthalmol. 2004 Sep;122(9):1316-23. Resumo

100. Silva RA, Dubovy SR, Hess D, et al. Hemorrhage as a sign of treatment failure after intra-arterial chemotherapy in retinoblastoma. J AAPOS. 2015 Jun;19(3):268-70. Resumo

101. Rivera GK, Pui CH, Santana VM, et al. Epipodophyllotoxins in the treatment of childhood cancer. Cancer Chemother Pharmacol. 1994;34 Suppl:S89-S95. Resumo

102. Azary S, Ganguly A, Bunin GR, et al. Sporadic Retinoblastoma and Parental Smoking and Alcohol Consumption before and after Conception: A Report from the Children's Oncology Group. PLoS One. 2016;11(3):e0151728.Texto completo  Resumo